Support ALK+ Research
Together with ALK+ patients, survivors, loved ones, and medical leaders, we’re fueling bold, life‑saving research to change the future of ALK+ lung cancer.
This research initiative requires $660,000 in total funding. Thanks to the generosity of many individual supporters, partner organizations, and Pfizer, we are within reach of our goal. We’re now inviting our community to help raise the final $130,000 needed to move this critical work forward.
Your support matters
We know that accelerating progress for ALK+ lung cancer requires a targeted investment.
This funding will fuel cutting-edge studies that aim to extend survival, improve quality of life, and ultimately move us closer to a cure. Our goal is to double down on research that can directly change outcomes for ALK+ patients and families who urgently need better answers.
We cannot do this alone.
Breakthroughs happen when passionate supporters, leading researchers, and strong partners come together to push the boundaries of science.
Please give, and help launch this critical initiative and inspire further fundraising efforts that will make this vision a reality!
Join us in fueling hope through research
These stories inspire our investment in ALK+ research. The people and families behind them are why this work matters. Want to share your story? Contact Natalie Finch at nfinch@LCRF.org.
Christine was a healthy, active woman with no previous health issues when she was diagnosed with stage 4 ALK+ lung cancer. Read her story
Kay was only 17 years old when she was diagnosed with ALK+ lung cancer. Now, her family is working to fuel research for others with this disease.
Jen, a mother of 3, was diagnosed with stage 4 ALK+ lung cancer in 2017. "I will do anything to stay here with my children." Read her story
About the research
With your support, LCRF will fund ALK+ lung cancer research focused on (but not limited to):
• Overcoming progression and metastasis
• Therapies beyond TKIs
• Immune recognition approaches
• Impact of co-mutations
Together, we can drive progress that saves lives, delivers hope, and brings us closer to a future without lung cancer.